Table 3.

Correlations between expression of genes involved in estrogen oxidative metabolism and demographic characteristics of endometrial cancer patients.

Gene	Age				Body mass				BMI				Age at menopause				Parity
	Rho	p	Adj. p	N	Rho	p	Adj. p	N	Rho	p	Adj. p	N	Rho	p	Adj. p	N	Rho	p	Adj. p	N
SULT1E1	0.192	0.255	0.850	37	0.127	0.461	0.922	36	0.122	0.499	0.998	33	-0.213	0.285	0.950	27	0.016	0.925	1.000	36
CYP1A1	0.287	0.085	0.850	37	-0.029	0.866	0.962	36	-0.045	0.803	1.000	33	0.003	0.989	0.989	27	-0.086	0.619	0.884	36
CYP1B1	0.021	0.900	0.900	37	-0.090	0.602	0.860	36	-0.027	0.881	0.881	33	0.040	0.844	1.000	27	-0.033	0.847	1.000	36
CYP1A2	0.238	0.157	0.785	37	-0.144	0.402	1.000	36	-0.119	0.508	0.847	33	0.048	0.811	1.000	27	0.173	0.312	1.000	36
CYP3A5	0.028	0.869	0.966	37	-0.130	0.450	1.000	36	-0.155	0.388	1.000	33	0.102	0.612	1.000	27	-0.129	0.453	0.906	36
CYP3A7	-0.157	0.353	0.883	37	-0.252	0.139	1.000	36	-0.218	0.222	1.000	33	-0.008	0.970	1.000	27	-0.231	0.175	0.875	36
COMT	-0.135	0.426	0.852	37	0.005	0.977	0.977	36	-0.029	0.874	0.971	33	0.209	0.295	0.738	27	-0.288	0.089	0.890	36
UGT2B7	0.117	0.490	0.817	37	0.047	0.786	0.983	36	0.032	0.859	1.000	33	0.318	0.106	0.530	27	0.008	0.963	0.963	36
SULT1A1	-0.051	0.765	0.956	37	-0.218	0.201	1.000	36	-0.205	0.253	1.000	33	0.059	0.771	1.000	27	-0.167	0.330	0.825	36
GSTP1	-0.071	0.684	0.977	35	0.109	0.538	0.897	34	0.140	0.453	1.000	31	0.511**	0.008	0.080	26	0.118	0.507	0.845	34

Spearman׳s rho correlation coefficient (Rho) and 2-tailed significance (p) and adjusted significance (Adj. p) and N number of endometrial cancer cases are shown. ** Correlation is significant at the 0.001 level (2-tailed).